Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.

被引：258

作者：

Tonelli, Marcello ^{[1
,2
]}

Pannu, Neesh ^{[1
,3
]}

Manns, Braden ^{[4
,5
]}

机构：

[1] Univ Alberta, Dept Med, Edmonton, AB, Canada

[2] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada

[3] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada

[4] Univ Calgary, Dept Med, Calgary, AB, Canada

[5] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 14期

基金：

加拿大健康研究院;

关键词：

CORONARY-ARTERY CALCIFICATION; CHRONIC-HEMODIALYSIS PATIENTS; CHRONIC-RENAL-FAILURE; LANTHANUM CARBONATE; CALCIUM-CARBONATE; SEVELAMER-HYDROCHLORIDE; DIALYSIS PATIENTS; MAGNESIUM CARBONATE; ALUMINUM-HYDROXIDE; SERUM PHOSPHORUS;

D O I：

10.1056/NEJMra0912522

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hyperphosphatemia, which is nearly universal in kidney failure, is accompanied by low serum levels of vitamin D and hypocalcemia. Without treatment, severe secondary hyperparathyroidism occurs, which may result in painful fractures, brown tumors, and generalized osteopenia. This article reviews the rationale for treatment with oral phosphate binders, discusses evidence supporting the use of available agents, and suggests an approach for clinical practice. Copyright © 2010 Massachusetts Medical Society. All rights reserved.

引用

页码：1312 / 1324

页数：13

共 109 条

[91] Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis [J].

Shigematsu, Takashi ;

Sakai, Takehiko ;

Iwasaki, Masashi ;

Nagakura, Kazutake ;

Murakami, Koichi ;

Kono, Takashi ;

Ando, Ken ;

Kimura, Yasuo ;

Sato, Junichi ;

Tsuruta, Yoshinari ;

Obayashi, Takaaki ;

Kanashiro, Kana ;

Seno, Hachiro ;

Mori, Yasumitsu ;

Murai, Hiroshi ;

Nakao, Naoyuki ;

Taki, Masafumi ;

Arimoto, Katsuhiko ;

Matsubara, Tatsuya ;

Moriishi, Misaki ;

Kawanishi, Hideki ;

Watanabe, Hiroshi ;

Minakuchi, Jun ;

Kato, Takuma ;

Hayashi, Ikuro ;

Kaibara, Akihito ;

Kawahara, Kazuhiko ;

Nishida, Hayato ;

Suzuki, Hiroko ;

Takeda, Isao ;

Kuwahara, Kazunori ;

Sugita, Osamu ;

Miyake, Susumu ;

Noguchi, Tomonaga ;

Yuasa, Kenji ;

Ota, Kazumichi ;

Terao, Naotami ;

Sen, Yasukazu ;

Iwasa, Yoshie ;

Ishida, Mari ;

Ishida, Yuji ;

Nakao, Shoko ;

Kobayashi, Takeshi ;

Yachiku, Setsuko ;

Komura, Chikashi ;

Yao, Naoyuki ;

Tsujimoto, Yoshihiro ;

Tabata, Tsutomu ;

Tahara, Hideki .

THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (01) :55-61

[92] Dietary Phosphorus Acutely Impairs Endothelial Function [J].

Shuto, Emi ;

Taketani, Yutaka ;

Tanaka, Rieko ;

Harada, Nagakatsu ;

Isshiki, Masashi ;

Sato, Minako ;

Nashiki, Kunitaka ;

Amo, Kikuko ;

Yamamoto, Hironori ;

Higashi, Yukihito ;

Nakaya, Yutaka ;

Takeda, Eiji .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (07) :1504-1512

[93] Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study [J].

Slinin, Y ;

Foley, RN ;

Collins, AJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1788-1793

[94] Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up [J].

Spasovski, Goce B. ;

Sikole, Aleksandar ;

Gelev, Saso ;

Masin-Spasovska, Jelka ;

Freemont, Tony ;

Webster, Isabel ;

Gill, Maggie ;

Jones, Chris ;

De Broe, Marc E. ;

D'Haese, Patrick C. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) :2217-2224

[95] Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study [J].

Spiegel, David M. ;

Farmer, Beverly ;

Smits, Gerard ;

Chonchol, Michel .

JOURNAL OF RENAL NUTRITION, 2007, 17 (06) :416-422

[96] Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4: A Randomized Trial [J].

Sprague, Stuart M. ;

Abboud, Hanna ;

Qiu, Ping ;

Dauphin, Matthew ;

Zhang, Pinggao ;

Finn, William .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01) :178-185

[97] Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders [J].

Sturtevant, JM ;

Hawley, CM ;

Reiger, K ;

Johnson, DW ;

Campbell, SB ;

Burke, JR ;

Bofinger, A ;

Isbel, NM .

NEPHROLOGY, 2004, 9 (06) :406-413

[98] Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients [J].

Suki, W. N. ;

Zabaneh, R. ;

Cangiano, J. L. ;

Reed, J. ;

Fischer, D. ;

Garrett, L. ;

Ling, B. N. ;

Chasan-Taber, S. ;

Dillon, M. A. ;

Blair, A. T. ;

Burke, S. K. .

KIDNEY INTERNATIONAL, 2007, 72 (09) :1130-1137

[99] Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial [J].

Sullivan, Catherine ;

Sayre, Srilekha S. ;

Leon, Janeen B. ;

Machekano, Rhoderick ;

Love, Thomas E. ;

Porter, David ;

Marbury, Marquisha ;

Sehgal, Ashwini R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (06) :629-635

[100] Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis [J].

Takei, Takashi ;

Otsubo, Shigeru ;

Uchida, Keiko ;

Matsugami, Keiko ;

Mimuro, Tomoko ;

Kabaya, Takashi ;

Akiba, Takashi ;

Nitta, Kosaku .

NEPHRON CLINICAL PRACTICE, 2008, 108 (04) :C278-C283

← 2 3 4 5 6 7 8 9 10 11 →